CI
RMD icon

Cavalier Investments’s ResMed RMD Stock Holding History

Cavalier Investments’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-5,100
Closed -$751K – 113
2020
Q1 		$751K Buy
+5,100
New +$812K 0.44% 54
2016
Q1 		– Sell
-3,800
Closed -$204K – 129
2015
Q4 		$204K Buy
+3,800
New +$214K 0.12% 108

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cavalier Investments's RMD Position: Q2 2020 in Review

Cavalier Investments sold out of ResMed (RMD) in Q2 2020, closing a stake of 5,100 shares — an estimated $751K sold.

Cavalier Investments first reported a position in RMD in Q4 2015 and held it in 2 quarters. The position peaked at $751K in Q1 2020. 582 funds tracked by Wall St. Rank hold RMD as of Q2 2020.

  • Cavalier Investments reported no remaining ResMed position as of Q2 2020 after selling out during the quarter.
  • Cavalier Investments sold 5,100 ResMed shares in Q2 2020, an estimated $751K.
  • Cavalier Investments first reported a position in ResMed in Q4 2015 and held it in 2 quarters.
  • Cavalier Investments's ResMed position peaked at $751K in Q1 2020.
  • 582 funds tracked by Wall St. Rank held ResMed as of Q2 2020.

Based on Cavalier Investments's 13F filing for Q2 2020, filed 10 Aug 2020.